ArticleFuture science OA2018

Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancer.

Saroj Niraula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.